Short Interest in Ascletis Pharma Inc. (OTCMKTS:ASCLF) Rises By 576.6%

Ascletis Pharma Inc. (OTCMKTS:ASCLF) was the recipient of a significant increase in short interest during the month of December. As of December 31st, there was short interest totaling 185,545 shares, an increase of 576.6% from the December 15th total of 27,422 shares. Based on an average daily trading volume, of 1,836 shares, the short-interest ratio is currently 101.1 days. Based on an average daily trading volume, of 1,836 shares, the short-interest ratio is currently 101.1 days.

Ascletis Pharma Trading Down 1.3%

Shares of OTCMKTS ASCLF opened at $1.53 on Tuesday. The company has a 50-day moving average price of $1.64 and a 200-day moving average price of $1.50. Ascletis Pharma has a 1 year low of $0.62 and a 1 year high of $2.29.

About Ascletis Pharma

Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.

The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).